Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Anastasopoulou · SciRah

Researcher profile · Semantic Scholar

E. Anastasopoulou

Share profile

E. Anastasopoulou — researcher profile on SciRah

h-index: 10
Works: 29
Citations: 424

Most-cited papers

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.
E. Mittendorf, A. Ardavanis, J. Symanowski, James L. Murray +11 more
2016Annals of Oncology106 citations Open access
Semantic Scholar
Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
S. Fortis, Sofopoulos Michail, Nectaria N. Sotiriadou, Christoforos Haritos +8 more
2017Journal of Immunotherapy for Cancer80 citations Open access
Semantic Scholar
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence
Tommy A. Ii Brown, E. Mittendorf, D. Hale, John W. Iii Myers +17 more
2020Breast Cancer Research and Treatment76 citations Open access
Semantic Scholar
AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial
S. Perez, E. Anastasopoulou, P. Tzonis, C. Gouttefangeas +3 more
2013Cancer Immunology and Immunotherapy31 citations
Semantic Scholar
AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and prediction
S. Perez, E. Anastasopoulou, M. Papamichail, C. Baxevanis
2014Cancer Immunology and Immunotherapy21 citations
Semantic Scholar
A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit
E. Anastasopoulou, I. F. Voutsas, T. Keramitsoglou, C. Gouttefangeas +5 more
2015Cancer Immunology and Immunotherapy20 citations Open access
Semantic Scholar
MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4+ T-cells
E. Anastasopoulou, I. F. Voutsas, M. Papamichail, C. Baxevanis +1 more
2016Oncoimmunology17 citations Open access
Semantic Scholar
Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical model
S. Fortis, L. Mahaira, E. Anastasopoulou, I. F. Voutsas +2 more
2017Cancer Immunology and Immunotherapy16 citations Open access
Semantic Scholar
Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide
I. F. Voutsas, E. Anastasopoulou, P. Tzonis, M. Papamichail +2 more
2016Journal of Immunotherapy for Cancer13 citations Open access
Semantic Scholar
Potential Prognostic Molecular Signatures in a Preclinical Model of Melanoma.
S. Fortis, E. Anastasopoulou, I. F. Voutsas, C. Baxevanis +2 more
2017Anticancer Research11 citations Open access
Semantic Scholar
Immune biomarkers: how well do they serve prognosis in human cancers?
C. Baxevanis, E. Anastasopoulou, I. F. Voutsas, M. Papamichail +1 more
2015Expert Review of Molecular Diagnostics9 citations
Semantic Scholar
Subgroup efficacy evaluation of the AE37 HER2 vaccine in breast cancer patients in the adjuvant setting.
Kaitlin M. Peace, E. Mittendorf, S. Perez, P. Tzonis +10 more
20178 citations
Semantic Scholar
From bench to bedside: The use of the li-Key technology to improve helper peptides for clinical use in cancer vaccines.
T. Vreeland, D. Hale, Alan K. Sears, G. Clifton +10 more
20124 citations
Semantic Scholar
Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
S. Fortis, Sofopoulos Michail, Nectaria N. Sotiriadou, Christoforos Haritos +8 more
2017Journal of Immunotherapy for Cancer3 citations Open access
Semantic Scholar
DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine
E. Anastasopoulou, P. Tzonis, S. Fortis, L. Mahaira +7 more
2015Journal of Immunotherapy for Cancer3 citations Open access
Semantic Scholar
Real-world management patterns in EGFR-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece.
Sofia Lampaki, G. Mountzios, V. Georgoulias, A. Rapti +13 more
2022Future Oncology2 citations
Semantic Scholar
7PDPreexisting immunity as a potential biomarker for clinical response to AE37 vaccination in breast cancer patients
N. Pistamaltzian, E. Anastasopoulou, P. Tzonis, J. Kalogeropoulou +6 more
20152 citations Open access
Semantic Scholar
An assessment of disease features and immune response in breast cancer patients that did not recur after receiving HER2 peptide, AE37 vaccine in a randomized phase II trial.
D. Hale, S. Perez, T. Vreeland, A. Trappey +13 more
20122 citations
Semantic Scholar
Evaluation of the Effect of Aspirin on Platelet Aggregation: Methodological Recommendations for Aspirin-Drug Interaction Studies
A. Kruithof, M. Moerland, E. Anastasopoulou, Pieter-Jan de Kam +2 more
20151 citations Open access
Semantic Scholar
Booster inoculations of the AE37 peptide vaccine enhance immunological responses in a phase II study.
E. Anastasopoulou, E. Pappou, P. Tzonis, A. Ardavanis +7 more
20131 citations
Semantic Scholar
Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study ‘LUNGFUL’
G. Mountzios, A. Koumarianou, H. Linardou, A. Boutis +23 more
2023Anticancer Research0 citations
Semantic Scholar
Lungful: An observational prospective study to assess the molecular epidemiology of EGFR mutations upon progression on or after first line EGFR-TKI therapy, in real-life clinical settings in Greece.
G. Mountzios, D. Mavroudis, E. Samantas, A. Koumarianou +12 more
20200 citations
Semantic Scholar
Effect of immunization with Ii-key modified HER2 (776-790) peptide vaccine (AE37) on immunologic responses in prostate cancer patients.
S. Perez, E. Anastasopoulou, E. Pappou, Panagiotis Tzonis +5 more
20170 citations
Semantic Scholar
Further insight into AE37 peptide vaccination in prostate cancer
E. Anastasopoulou, I. F. Voutsas
2017Future Science OA0 citations Open access
Semantic Scholar
Life as an early career researcher: interview with Eleftheria Anastasopoulou
E. Anastasopoulou
2016Future Science OA0 citations Open access
Semantic Scholar
S209 AE37 hybrid peptide vaccine induces clinical efficacy in boosted prostate cancer patients
S. Stokidis, S. Perez, V. Klapsas, E. Anastasopoulou +4 more
20130 citations
Semantic Scholar
C164 AE37 peptide vaccination in prostate cancer induces long-lasting immunological memory and clinical efficacy
C. Baxevanis, E. Anastasopoulou, P. Tzonis, A. Thanos +2 more
20130 citations
Semantic Scholar
Abstract LB-218: Immune response assessment in a phase II trial of AE37 HER2 peptide vaccine
D. Hale, T. Vreeland, R. Dabney, G. Clifton +10 more
20120 citations
Semantic Scholar
Effect of immunization with the ii-key modified HER2/neu(776-790) (AE37) peptide vaccine on pre-existent immunity to PSA in HLA-A24+ prostate cancer patients: Association with increased AE37-specific immunologic responses.
S. Perez, E. Anastasopoulou, E. Pappou, Nikolaos Fragkiskos Pistamaltzian +3 more
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Perez×22
Invite
S. Perez — researcher profile on SciRah
C. Baxevanis×19
Invite
C. Baxevanis — researcher profile on SciRah
M. Papamichail×15
Invite
M. Papamichail — researcher profile on SciRah
A. Ardavanis×11
Invite
A. Ardavanis — researcher profile on SciRah

×9

Invite

E. Mittendorf — researcher profile on SciRah

Invite

G. Peoples — researcher profile on SciRah

Invite

P. Tzonis — researcher profile on SciRah

I. F. Voutsas×7

Invite

I. F. Voutsas — researcher profile on SciRah

Invite

D. Hale — researcher profile on SciRah

Invite

S. Ponniah — researcher profile on SciRah

Invite

E. Pappou — researcher profile on SciRah

Invite

N. Shumway — researcher profile on SciRah